MagellanRx - STATE OF TENNESSEE DIVISION OF TENNCARE

Effective March 7, 2018

Author: Erica Lawrence/Monday, February 19, 2018/Categories: APCI Choice

This notice is being sent to notify you of changes for the TennCare pharmacy program. We encourage you to read this notice thoroughly and contact Magellan’s Pharmacy Support Center (866-434-5520) should you have additional questions.

Removal of agents from list of branded agents classified as generics

Effective March 7, 2018, the following agent will be removed from the list of branded agents classified as generics meaning that it will now count as a brand toward members’ monthly prescription limits and copays. Any requests for this brand name agent will require a new prior authorization effective March 7, 2018. 

* CUTIVATE 0.05% LOTION 

* XENAZINE PA

*Please see attached for more information*

Comments are only visible to subscribers.